Human Genome Epidemiology Literature Finder
Records 1 - 5 (of 5 Records) |
Query Trace: Thrombosis and ALK[original query] |
---|
Risk of thromboembolism in patients with ALK- and EGFR-mutant lung cancer: A cohort study. Journal of thrombosis and haemostasis : JTH 2020 12 19 (3): 822-829. Roopkumar Joanna, Poudel Shyam K, Gervaso Lorenzo, Reddy Chandana A, Velcheti Vamsidhar, Pennell Nathan A, McCrae Keith R, Khorana Alok |
Venous thromboembolism incidence in cancer patients with germline BRCA mutations. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2021 Aug . Muñoz A J, de Toro M, Ortega L, López C, Gutiérrez A, Juliao D S, Arregui M, Lobato N, Echavarría I, Márquez-Rodas I, Martín |
Common genetic driver mutation in NSCLC and their association with thromboembolic events: A retrospective study. Lung cancer (Amsterdam, Netherlands) 2022 10 172 29-34. Lin Miaozhen, Lu Yujuan, Yu Qiwen, Chen Zebin, Peng Jiayu, Cai Xiu |
Risk of thromboembolism in non-small-cell lung cancers patients with different oncogenic drivers, including ROS1, ALK, and EGFR mutations. ESMO open 2022 Dec 7 (6): 100742. Wang H-Y, Wu S-G, Lin Y-T, Chen C-Y, Shih J |
Genomic and clinicopathological features of lung adenocarcinomas with micropapillary component. Frontiers in oncology 2022 12 12 989349. Li Peng, Liu Lu, Wang Dong, Yang Ronghua, Xuan Yunpeng, Han Yudong, Wang Jinglong, Guo Lijie, Zhang Liwen, Zhang Shanshan, Wang Yongj |
- Page last reviewed:Feb 1, 2024
- Content source: